ADAPTIVE BIOTECHNOLOGIES COR COM is a security (CUSIP 00650F109) tracked across SEC portfolio filings. 294 institutional managers reported $1.9B on Form 13F as of 2026-06-30; 35 registered fund positions totaling $153.9M via N-PORT as of 2026-05-31.
Showing 15 of 294 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | STAMFORD, CT | $416.3M | 29,993,708 |
| BlackRock, Inc. | New York, NY | $184.6M | 13,303,025 |
| VANGUARD GROUP INC | Valley Forge, PA | $183.2M | 11,282,152 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | BOSTON, MA | $75.5M | 5,436,718 |
| WELLINGTON MANAGEMENT GROUP LLP | BOSTON, MA | $53.5M | 3,857,422 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $50.5M | 3,636,054 |
| GOLDMAN SACHS GROUP INC | NEW YORK, NY | $45.0M | 3,242,077 |
| STATE STREET CORP | BOSTON, MA | $44.8M | 3,227,245 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | Paris, I0 | $37.3M | 2,688,081 |
| ARK Investment Management LLC | St. Petersburg, FL | $29.1M | 2,092,969 |
| FRED ALGER MANAGEMENT, LLC | NEW YORK, NY | $28.6M | 2,063,146 |
| Sumitomo Mitsui Trust Group, Inc. | CHIYODA-KU, TOKYO, M0 | $28.5M | 1,329,856 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | BOSTON, MA | $27.7M | 1,995,202 |
| D. E. Shaw & Co., Inc. | New York, NY | $27.3M | 1,965,610 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | PHILADELPHIA, PA | $26.1M | 1,881,183 |
Showing 15 of 35 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| LORD ABBETT DEVELOPING GROWTH FUND INC | LORD ABBETT DEVELOPING GROWTH FUND, INC. | $23.9M | 107.81% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $18.4M | 2.26% |
| Master Focus Growth LLC | Master Focus Growth LLC | $16.9M | 90.19% |
| Columbia Acorn Fund | COLUMBIA ACORN TRUST | $15.9M | 70.99% |
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $11.6M | 6.64% |
| Oberweis Micro-Cap Fund | OBERWEIS FUNDS | $10.8M | 102.37% |
| abrdn Healthcare Investors | abrdn Healthcare Investors | $9.4M | 82.48% |
| Optimum Small-Mid Cap Growth Fund | Optimum Fund Trust | $5.7M | 74.53% |
| T. Rowe Price Small-Cap Stock Fund, Inc. | T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | $5.6M | 6.92% |
| abrdn Life Sciences Investors | abrdn Life Sciences Investors | $5.5M | 97.75% |
| VANGUARD EXPLORER FUND | VANGUARD EXPLORER FUND | $5.1M | 2.35% |
| Master Small Cap Index Series | Quantitative Master Series LLC | $3.3M | 6.94% |
| Bridge Builder Tax Managed Small/Mid Cap Fund | Bridge Builder Trust | $3.3M | 10.87% |
| T. Rowe Price Institutional Small-Cap Stock Fund | T. Rowe Price Equity Funds, Inc. | $3.1M | 7.04% |
| Embark Small Cap Equity Fund | Harbor Funds II | $1.7M | 29.17% |